comprehensive -WSS

comprehensive

author：entertainment 2025-09-27 22:49:29 - browse：74

Illumina building. -- biotech coverage from STAT — Adobe

LONDON — The European Union on Wednesday issued an antitrust fine of $475 million to the U.S. genetic sequencing giant Illumina for closing its acquisition of cancer detection company Grail before clearing it with regulators.

The fine amounts to nearly 10% of Illumina’s annual global revenue, which is the most the European Commission can penalize a company under its merger regulations. The commission called Illumina’s actions “an unprecedented and very serious infringement” of the EU’s policies, including the “cornerstone” that regulators review deals that can alter the market.

The commission also issued what it called a symbolic fine of 1,000 Euros, or about $1,100, to Grail for what it said was the firm’s “active role” in the deal’s infringement of EU rules.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： FDA's Pazdur wants cancer trials to range beyond China alone

focus

WSS

Intellia reports positive results for its CRISPR

AI for drug discovery: Experts on separating hype from reality

Intellia reports positive results for its CRISPR

Class action alleges UnitedHealth concealed DOJ probe

Chemotherapy before breast cancer surgery might fuel metastasis

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

knowledge

comprehensive

entertainment

Walensky prepares to leave CDC — and Congress — behind

Ionis drug prevents swelling attacks due to hereditary angioedema

Duchenne breakthrough therapy leaves behind pioneering families

As health system earnings go up, health insurance stocks go down

Heart attack and stroke risk calculators need revising

Has Bernie Sanders reached the limit of his pharma bullying effort?

Activists slam private health insurers over coverage restrictions

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

DIEP, the 'gold standard' of breast reconstruction, is under threat

Can gargling with Listerine treat gonorrhea of the mouth?

entertainment

At ASCO, AstraZeneca reports strong data for breast cancer drug

Class action alleges UnitedHealth concealed DOJ probe

The creative science of coining drug names

PBM executives asked to testify by House panel

See how much Covid

Letters to First Opinion on caregivers, digital health, and more

knowledge

focus

leisure time

focus